construction, Hovnanian Enterprises, Inc., New Products/Services, New York Stock Exchange, Real Estate and Construction-Construction, Uncategorized
KING ABDULLAH ECONOMIC CITY (KAEC), Saudia Arabia, July 30, 2025 (GLOBE NEWSWIRE) — Emaar, The Economic City (EEC), the master developer of King Abdullah Economic City (KAEC), has signed an agreement with Al Tahaluf, a Saudi–American joint venture comprised of a K. Hovnanian subsidiary and the Hamad bin Saedan Real Estate Company, to develop two […]
Computers and Software-Hardware, Debit My Data, Inc., hardware, New Products/Services, Uncategorized
DebitMyData™ Logo FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion–dollar global rollout of DebitMyData™’s Human Energy Grid, setting a new standard for individual data ownership, ethical monetization, […]
Clinical Study, Dr. Falk Pharma, Drugs, Miscellaneous, Partnerships, Pharmaceuticals and Biotech-Drugs, Uncategorized
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025: Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR–Agonisten zur Behandlung mittelschwerer bis schwerer Colitis ulcerosa bekannt. Dr. Falk Pharma GmbH, ein forschungsbasiertes Pharmaunternehmen und Spezialist für Verdauungs– und Stoffwechselmedizin, und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd., […]
Clinical Study, Dr. Falk Pharma, Drugs, Miscellaneous, Partnerships, Pharmaceuticals and Biotech-Drugs, Uncategorized
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis Dr. Falk Pharma GmbH, a research–based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]
Bitget Limited, Commercial and Investment Banking, Financial Services-Commercial and Investment Banking, New Products/Services, Uncategorized
VICTORIA, Seicheles, July 30, 2025 (GLOBE NEWSWIRE) — A Bitget, a corretora de criptomoedas líder e empresa de Web3, anunciou a apresentação da Gaia (GAIA) na sua launchpool, bem como um registo para negociação à vista. Gaia é uma infraestrutura de computação descentralizada que permite a todos criarem, implementarem, escalarem e rentabilizarem os seus próprios […]
Bitget Limited, Commercial and Investment Banking, Financial Services-Commercial and Investment Banking, New Products/Services, Uncategorized
VICTORIA, Seychelles, 30 juill. 2025 (GLOBE NEWSWIRE) — Bitget, première bourse de cryptomonnaies et société Web3, annonce l’intégration de Gaia (GAIA) sur son Launchpool et sa cotation sur sa plateforme de trading au comptant. Gaia est un réseau décentralisé permettant à chacun de créer, déployer, faire évoluer et monétiser ses propres agents IA. Les transactions […]
Ambiq, Computers and Software-Hardware, hardware, Initial Public Offerings, Uncategorized
AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra–low–power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common stock at a public offering price of $24.00 per share. The gross proceeds to Ambiq from the […]
Euronext Brussels, Medical and Healthcare-Medical Devices, medical devices, Miscellaneous, NASDAQ, Nyxoah, Uncategorized
REGULATED INFORMATION Information on the total number of voting rights and shares Mont–Saint–Guibert (Belgium), July 29, 2025, 10:45 pm CET / 4:45 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. […]
Euronext Brussels, Medical and Healthcare-Medical Devices, medical devices, Miscellaneous, NASDAQ, Nyxoah, Uncategorized
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont–Saint–Guibert (Belgique), le 29 juillet 2025, 22:45h CET / 16:45h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publie les informations ci–dessous suite à l'émission de […]
Euronext Brussels, Medical and Healthcare-Medical Devices, medical devices, Miscellaneous, NASDAQ, Nyxoah, Uncategorized
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont–Saint–Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results […]
Omani Rial Exchange Rate